Shionogi invested 2,125 million USD to acquire 21.7% of shares in ViiV Healthcare Ltd., completing the equity-method affiliate status.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4507","jir_company_name":"Shionogi & Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-04-01","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/04\/4507-20260401-01.pdf","jir_short_summary":"Shionogi invested 2,125 million USD to acquire 21.7% of shares in ViiV Healthcare Ltd., completing the equity-method affiliate status.","jir_summary":"### Overview of M&A\nShionogi & Co., Ltd. announced on January 20, 2026, an additional investment of 2,125 million USD in ViiV Healthcare Ltd., receiving newly issued shares from ViiV. As a result, Shionogi holds a total of 21.7% of shares, including an 11.7% voting rights ratio, and ViiV became an equity-method affiliate.\n\n### Future Outlook and Impact on Shareholders\nShionogi positions 'liberation from the threat of infectious diseases' as a key challenge and promotes initiatives against the three major infectious diseases, focusing on HIV infection. Through this investment, Shionogi aims to strengthen partnerships with ViiV and GSK and contribute further to global HIV treatment and prevention. Shareholders are expected to see performance impacts linked to the equity-method affiliate status, though specific financial effects are not disclosed.","jir_financial_highlights":"Investment Amount: 2,125 million USD (Unknown)\nVoting Rights Ratio: 11.7% (Unknown)\nShare Ownership Ratio: 21.7% (Unknown)","jir_category":"","jir_hashtags":"#ShionogiAndCoLtd, #M&A, #JapaneseStocks","jir_key_figures":"Investment Amount: 2,125 million USD\nVoting Rights Ratio: 11.7%\nShare Ownership Ratio: 21.7%","jir_meta_title":"Shionogi Completes Acquisition of 21.7% Shares in ViiV Healthcare Ltd. with 2,125 Million USD Investment","jir_meta_description":"Shionogi invested 2,125 million USD to acquire 21.7% of shares in ViiV Healthcare Ltd., completing equity-method affiliate status. Aiming to strengthen partnerships in the field of HIV treatment.","jir_og_title":"Shionogi Completes Acquisition of 21.7% Shares in ViiV Healthcare","jir_og_description":"Shionogi has acquired 21.7% of shares in ViiV Healthcare Ltd., completing equity-method affiliate status. This marks an important step toward strengthening infectious disease countermeasures.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":6919,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"m_and_a_alliance","footnotes":""},"sector":[],"importance":[],"class_list":["post-38466","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n